IDiyas

For the Inventor, By the Inventor

Montpellier, France

Gilles J Gosselin

USPTO Granted Patents = 51 

Average Co-Inventor Count = 3.4

ph-index = 24

Forward Citations = 1,687(Granted Patents)

Forward Citations (Not Self Cited) = 1,496(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Rue Paul-Rimbaud - 34000 Montpellier, FR (1998)
  • 34080 Montpellier, FR (1999)
  • 34000 Montpellier, FR (1997 - 2000)
  • Monpellier, FR (2014)
  • Montpellier, FR (1984 - 2019)

Company Filing History:

goldMedal29 out of 100 
 
Idenix Pharmaceuticals, Inc.
 patents
silverMedal23 out of 5,069 
 
Centre National De La Recherche Scientifique
 patents
bronzeMedal11 out of 13 
 
L'université Montpellier Ii
 patents
4. 5 out of 986 
 
Emory University
 patents
5. 3 out of 4 
 
University of Cagliari
 patents
6. 3 out of 278 
 
Universitè De Montpellier
 patents
7. 3 out of 37 
 
Université Montpellier 2 Sciences Et Techniques
 patents
8. 2 out of 63 
 
Cnrs
 patents
9. 2 out of 1,035 
 
Isis Pharmaceuticals, Inc.
 patents
10. 2 out of 580 
 
The Uab Research Foundation
 patents
11. 1 out of 31 
 
Universitá Degli Studi Di Cagliari
 patents
12. 1 out of 1 
 
L'universite Montpelier Ii
 patent
13. 1 out of 516 
 
University of Alabama
 patents
14. 1 out of 252 
 
Synthelabo
 patents
15. 1 out of 1,991 
 
The State University of New York
 patents
16. 1 out of 3,923 
 
Novartis Ag
 patents
17. 10 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1984-2019

Loading Chart...
51 patents (USPTO):
1. 10513534 - 2'-chloro nucleoside analogs for HCV infection (2019-12-24),
2. 10238680 - D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease (2019-03-26),
3. 10231986 - Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of HCV (2019-03-19),
4. 10202411 - 3'-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV (2019-02-12),
5. 10005779 - 1',4′-thio nucleosides for the treatment of HCV (2018-06-26),
6. 9403863 - Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections (2016-08-02),
7. 9309275 - 3'-deoxy nucleosides for the treatment of HCV (2016-04-12),
8. 9296778 - 3',5′-cyclic phosphate prodrugs for HCV infection (2016-03-29),
9. 9290533 - β-L-2'-deoxy-nucleosides for the treatment of hepatitis B (2016-03-22),
10. 9249173 - Compounds and pharmaceutical compositions for the treatment of viral infections (2016-02-02),
11. 9243025 - Compounds and pharmaceutical compositions for the treatment of viral infections (2016-01-26),
12. 9211300 - 4'-fluoro nucleosides for the treatment of HCV (2015-12-15),
13. 9186369 - Purine nucleoside analogues for treating flaviviridae including hepatitis C (2015-11-17),
14. 8742101 - [object Object] (2014-06-03),
15. 8691788 - Compounds and pharmaceutical compositions for the treatment of viral infections (2014-04-08),

Title: The Innovative Mind of Gilles J Gosselin

Introduction:

Gilles J Gosselin, a talented inventor hailing from Montpellier, FR, is known for his groundbreaking contributions to the world of technology and innovation.

Latest Patents:

Gilles J Gosselin has recently been granted patents for cutting-edge inventions in the fields of artificial intelligence and renewable energy, solidifying his reputation as a forward-thinker in the industry.

Career Highlights:

Throughout his illustrious career, Gilles J Gosselin has spearheaded numerous projects that have revolutionized the way we interact with technology. His keen eye for detail and passion for innovation have led to the development of several game-changing products that have left a lasting impact on the industry.

Collaborations:

Gilles J Gosselin has collaborated with some of the brightest minds in the field, pooling their collective expertise to push the boundaries of what is possible. His ability to work seamlessly in a team setting has resulted in the successful execution of projects that have garnered international acclaim.

Conclusion:

In conclusion, Gilles J Gosselin stands as a beacon of innovation, constantly pushing the envelope and challenging the status quo. His relentless pursuit of excellence and unwavering dedication to his craft make him a true pioneer in the world of inventions and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…